Dementia for 2

Recently I received an email from Karen Halsey regarding a new clinical study for the drug bapineuzumab.

Since my grandmother is not eligible for this trial, I have agreed to post the information she provided so that any of my readers that are interested can get in touch with the right people for this study. Below is the email I received with all the information. I hope that this study will prove beneficial to anyone who is suffering from this disease.

Physicians in the United States and Canada are looking for volunteers to participate in the ICARA study, a clinical study evaluating the safety and effectiveness of an investigational drug (bapineuzumab) that may help slow the progression of Alzheimer’s disease.



They are looking for men and women who:

· Are between 50 and 89 years of age,

· Have a diagnosis of mild to moderate Alzheimer’s disease, and

· Have a caregiver who is willing to be involved in the study with them.



Study participants will join more than 2,050 volunteers at 200 study sites across the U.S. and Canada. The study will last up to 83 weeks and all study-related procedures and medication will be provided at no cost. There is no charge to participate in this study. During the study, each participant will be monitored by a medical team, including a physician.



For more information about the trial, www.ICARAstudy.com or call 1-888-770-6366.